Apr 16, 2007 | Laboratory News, Laboratory Sales and Marketing
Here’s the latest shake-up to the laboratory testing marketplace. Quest Diagnostics Incorporated announced this morning that it will acquire AmeriPath, Inc. in a transaction valued at $2 billion. Both parties expect the deal to close before June 30, 2007. AmeriPath’s annual revenues are in excess of $800 million. Quest will pay $1.23 billion in cash and assume about $770 million of debt when the transaction closes. With its purchase of AmeriPath, Quest Diagnostics picks up three diverse...